A Novel Technique of Aseptic Manufacture of Autologous Serum Eye Drops (ASEDs) and Sterility Analysis of the Bottled Ophtioles
Klinische Monatsblätter für Augenheilkunde · 01.04.2024 · 241 (04) · 392-397
DOI: 10.1055/a-2249-0056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Klinische Monatsblätter für Augenheilkunde, erschienen am 01.04.2024. Verfasst von Frank Blaser und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, UniversitätsSpital Zürich, Switzerland. Hauptthemen laut MEDLINE: Ophthalmic Solutions, Drug Contamination, Serum. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Purpose
To introduce a novel technique of the aseptic manufacture of autologous serum eye drops (ASEDs) with a prefiltered closed system and to analyze the sterility of the produced ophtioles between 2018 and 2022.
Methods
This is a prospective single-center study conducted at the Department of Ophthalmology at a Swiss University Hospital between 2018 and 2022. For regulatory reasons, closed systems for manufacturing ASEDs are strongly recommended. We attached an upstream sterile filter (Sterivex PES0.22 µm Burlington, USA) to a commercially available closed system (COL System Modena, Italy) for manufacturing ASEDs. The goal of this novel approach was to reduce the microbiological contamination of the donated autologous blood. Using the presented manufacturing method, we are able to produce, on average, 56 ophtioles per batch, containing either 1.45 mL or 2.5 mL of autologous serum per ophtiole. For each batch of ASEDs, we performed a microbiological analysis by automated blood culture testing (BACTEC). This system examines the presence of bacteria and fungi.
Results
We analyzed all manufactured batches between 2018 and 2022. None of the 2297 batches and the resulting 129 060 ophtioles showed bacterial or mycotic contamination. During the analyzed period, two batches were discarded: one due to fibrin-lipid aggregations, further microbiological and histological work-up excluded any contamination; another due to false-positive HIV in serological testing. Overall, the contamination rate was 0%, and the batch discharge rate was 0.09%.
Conclusions
The combination of upstream sterile filtration with a commercial closed system for manufacturing ASEDs proved to be effective in ensuring sterility without any contamination over the past 4 years. This is becoming crucial, as the demand for autologous blood products for treating ocular surface disorders, such as refractory dry eyes or nonhealing defects of the corneal epithelium, is on the rise.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, UniversitätsSpital Zürich, Switzerland.
- Department of Pathology and Molecular Pathology, UniversitätsSpital Zürich, Switzerland.
- Department of Clinical Neuro Science, Karolinska Institutet, Stockholm, Sweden.
- Save Sight Institute, University of Sydney CAR, Glebe, Australia.
ORCID-Profile: Daniel Barthelmes, Sandrine Zweifel, Sadiq Said, Anahita Bajka
Zitieren
APA
Blaser, F., Meneau, I., Mihic-Probst, D., Muth, D. R., Barthelmes, D., Zweifel, S., Said, S., & Bajka, A. (2024). A Novel Technique of Aseptic Manufacture of Autologous Serum Eye Drops (ASEDs) and Sterility Analysis of the Bottled Ophtioles. Klinische Monatsblätter für Augenheilkunde, 241(04), 392-397. https://doi.org/10.1055/a-2249-0056
Vancouver
Blaser F, Meneau I, Mihic-Probst D, Muth DR, Barthelmes D, Zweifel S, et al. A Novel Technique of Aseptic Manufacture of Autologous Serum Eye Drops (ASEDs) and Sterility Analysis of the Bottled Ophtioles. Klinische Monatsblätter für Augenheilkunde. 2024;241(04):392-397. doi:10.1055/a-2249-0056
BibTeX
@article{Blaser2024,
author = {Blaser, Frank and Meneau, Isabelle and Mihic-Probst, Daniela and Muth, Daniel Rudolf and Barthelmes, Daniel and Zweifel, Sandrine and Said, Sadiq and Bajka, Anahita},
title = {A Novel Technique of Aseptic Manufacture of Autologous Serum Eye Drops (ASEDs) and Sterility Analysis of the Bottled Ophtioles},
journal = {Klinische Monatsblätter für Augenheilkunde},
year = {2024},
volume = {241},
number = {04},
pages = {392--397},
doi = {10.1055/a-2249-0056}
}
EUVIMED